La asociación de materiales magnéticos y termo-sensibles: posibilidades y algunas aplicaciones biomédicas actuales

Título: La asociación de materiales magnéticos y termo-sensibles: posibilidades y algunas aplicaciones biomédicas actuales.Gerardo F. Goya

Biography

Dr. Gerardo F. Goya is currently Associate Professor at the University of Zaragoza, Spain. He competed his PhD degree at the University of La Plata, Argentina. During 2001-2007 has been Associate Professor at the Institute of Physics, University of Sao Paulo (Brazil), where he created and managed the mechanochemistry laboratory at the Materials Physics Department (DFMT).

After joining the Institute of Nanoscience of Aragón (INA), University of Zaragoza, in 2005 started and consolidated a new research line on nanomagnetism and biomedical applications of nanoparticles (NPs), mainly magnetic hyperthermia. The achievements in this period include new methods of synthesis of magnetic NPs with improved control of size and magnetic properties, and the successful proof of principle of the so-called ‘Trojan Horse strategy’ for oncologic therapy, by inducing cell death with magnetic hyperthermia in dendritic-cell primary cultures.  In addition, the group has developed several studies of different biological agents as models of interaction with magnetic NPs. As for the technological achievements, Prof. Goya has lead the design, development and building of unique equipment for measuring power absorption in magnetic hyperthermia. This is a pioneer system with many technological improvements designed to make a fully automatic measuring system. The innovation of these activities made the basis for a spin off company from the University of Zaragoza, of which he is co-founder and scientific advisor. He has more than 140 international publications with an h-index h=33, 2 PCT patents and more than 100 conference presentations including 30 invited talks. His work has established an internationally recognized research group in biomedical applications of magnetic nanoparticles, composed of engineers, biologists, chemists, and physicists. In collaboration with top-level parasitologists, immunologists and medical doctors, the group has managed to consolidate a common platform in biomedicine, which is reflected in the coordination of highly innovative multinational projects.